Adarx Pharmaceuticals
ADRX
12.79
-1.37
-9.68%
Adarx Pharmaceuticals
US · ADRX
#2823 by market cap
Listed 2026
12.79
-1.37
-9.68%
Periodic snapshot; not a real-time feed.
· 2026-11-20 20:02
Recent news
-
Earnings Flash (ADRX) ADARx Pharmaceuticals, Inc. Reports Q3 Revenue $2.2M, Vs. FactSet Est of $2.6MMT Newswires · 2026/11/13
-
Emerging siRNA developer ADARx (ADRX.US) has launched a $350 million IPO, with AbbVie subscribing to a 4.9% stake and committing up to $100 million.Zhitong Finance · 2026/9/22
-
A Quick Look at Today's Ratings for Adarx Pharmaceuticals(ADRX.US), With a Forecast Between $32 to $38Market Newswire · 2026/10/21
Headlines are aggregated automatically and are not independently verified or edited by our team.
Quote time 2026-11-20 20:02:38 · For reference only, not investment advice and not tailored to your situation.
Adarx Pharmaceuticals discussion 0 comments